Neuros Medical Competitors and Similar CompaniesClear all

Neuros Medical's competitors and similar companies include PAVmed, Bonutti Technologies, MGC Diagnostics and Miltenyi Biotec.

	Neuros Medical Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on developing proprietary therapies for unmet needs to patients worldwide.	PAVmed PAVmed is a company that provides medical technology.	Bonutti Technologies Bonutti Technologies is a medical product development and treatment research company.	MGC Diagnostics MGC Diagnostics Corporation is a global medical technology company dedicated to cardiorespiratory health solutions.	Miltenyi Biotec Miltenyi Biotec is a company that specializes in biomedical research and cell and gene therapy.
Founding Date	Founding Date 2008	Founding Date 2014	Founding Date 1990	Founding Date 1977	Founding Date 1989
Type	Type Private	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare clinical research medical devices medtech	Tags Technology medical devices medical diagnostics medical records oncology	Tags Healthcare clinical research medical devices medtech	Tags Healthcare clinical research medical devices medtech	Tags Healthcare biotech clinical research ecommerce medical devices oncology
Locations	Locations Willoughby Hills, US HQ	Locations New York, US HQ New York, US	Locations Effingham, US HQ	Locations Saint Paul, US HQ	Locations Bergisch Gladbach, DE HQ Sydney, AU Shanghai, CN Paris, FR Bielefeld, DE Cologne, DE Göttingen, DE see more
Employees	Employees 422% increase	Employees 10714% decrease	Employees 13	Employees 169	Employees 3,0341% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $71k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $40m (FY, 2016)	Revenue (est.) €671.5m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods $218k (FY, 2025)	Cost of goods N/A	Cost of goods $19.9m (FY, 2016)	Cost of goods €132.2m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit ($147k) (FY, 2025)	Gross profit N/A	Gross profit $20.2m (FY, 2016)	Gross profit €539.4m (FY, 2023)
Net income	Net income N/A	Net income ($2.5m) (FY, 2025)	Net income N/A	Net income ($3.8m) (FY, 2016)	Net income €11.4m (FY, 2023)